Takaaki Kobayashi1,2,3, Brice Beck2,3, Aaron Miller4, Philip Polgreen1, Amy M J O'Shea1,2,3, Michael E Ohl1,2,3. 1. Department of Internal Medicine, University of Iowa, Iowa City, Iowa, USA. 2. Center for Access & Delivery Research & Evaluation, Iowa City VA Health Care System, Iowa City, Iowa, USA. 3. VA office of Rural Health, Veterans Rural Health Resource Center-Iowa City, Iowa City, Iowa, USA. 4. Department of Epidemiology, University of Iowa, Iowa City, Iowa, USA.
Abstract
BACKGROUND: Prior studies have used International Classification of Disease (ICD) diagnosis codes in administrative data to identify patients with infective endocarditis (IE) associated with intravenous drug use (IVDU). Little is known about the accuracy of ICD codes for IVDU-IE. METHODS: We used 2 previously described algorithms to identify patients with potential IVDU-IE admitted to 125 Veterans Administration hospitals from January 2010 through December 2018. Algorithm A identified patients with concurrent ICD-9/10 codes for IE and drug use during the same admission. Algorithm B identified patients with drug use coded either during the IE admission or during outpatient or other visits within 6 months of admission. We reviewed 400 randomly selected patient charts to determine the positive predictive value (PPV) of each algorithm for clinical documentation of IE, any drug use, IVDU, and IVDU-IE, respectively. RESULTS: Algorithm A identified 788 patients, and B identified 1314 patients, a 68% increase. PPVs were high for clinical documentation of diagnoses of IE (86.5% for A and 82.6% for B) and any drug use (99.0% and 96.3%). PPVs were lower for documented IVDU (74.5% and 64.1%) and combined diagnoses of IVDU-IE (65.0% and 55.2%), partly because of a lack of ICD codes specific to IVDU. Among patients identified by algorithm B but not A, 72% had clinical documentation of drug use during the IE admission, indicating a failure of algorithm A to capture cases due to incomplete recording of inpatient ICD codes for drug use. CONCLUSIONS: There is need for improved algorithms for IVDU-IE surveillance during the ongoing opioid epidemic. Published by Oxford University Press on behalf of Infectious Diseases Society of America 2020.
BACKGROUND: Prior studies have used International Classification of Disease (ICD) diagnosis codes in administrative data to identify patients with infective endocarditis (IE) associated with intravenous drug use (IVDU). Little is known about the accuracy of ICD codes for IVDU-IE. METHODS: We used 2 previously described algorithms to identify patients with potential IVDU-IE admitted to 125 Veterans Administration hospitals from January 2010 through December 2018. Algorithm A identified patients with concurrent ICD-9/10 codes for IE and drug use during the same admission. Algorithm B identified patients with drug use coded either during the IE admission or during outpatient or other visits within 6 months of admission. We reviewed 400 randomly selected patient charts to determine the positive predictive value (PPV) of each algorithm for clinical documentation of IE, any drug use, IVDU, and IVDU-IE, respectively. RESULTS: Algorithm A identified 788 patients, and B identified 1314 patients, a 68% increase. PPVs were high for clinical documentation of diagnoses of IE (86.5% for A and 82.6% for B) and any drug use (99.0% and 96.3%). PPVs were lower for documented IVDU (74.5% and 64.1%) and combined diagnoses of IVDU-IE (65.0% and 55.2%), partly because of a lack of ICD codes specific to IVDU. Among patients identified by algorithm B but not A, 72% had clinical documentation of drug use during the IE admission, indicating a failure of algorithm A to capture cases due to incomplete recording of inpatient ICD codes for drug use. CONCLUSIONS: There is need for improved algorithms for IVDU-IE surveillance during the ongoing opioid epidemic. Published by Oxford University Press on behalf of Infectious Diseases Society of America 2020.
Entities:
Keywords:
International Classification of Disease codes; infective endocarditis; intravenous drug use; positive predictive value; veterans
Authors: Sarah E Rudasill; Yas Sanaiha; Alexandra L Mardock; Habib Khoury; Hanning Xing; James W Antonios; James A McKinnell; Peyman Benharash Journal: J Am Coll Cardiol Date: 2019-02-12 Impact factor: 24.094
Authors: Laura J Ball; Adeel Sherazi; Dora Laczko; Kaveri Gupta; Sharon Koivu; Matthew A Weir; Tina Mele; Rommel Tirona; John K McCormick; Michael Silverman Journal: Med Care Date: 2018-10 Impact factor: 2.983
Authors: Marin L Schweizer; Michael R Eber; Ramanan Laxminarayan; Jon P Furuno; Kyle J Popovich; Bala Hota; Michael A Rubin; Eli N Perencevich Journal: Infect Control Hosp Epidemiol Date: 2011-02 Impact factor: 3.254
Authors: Hude Quan; Vijaya Sundararajan; Patricia Halfon; Andrew Fong; Bernard Burnand; Jean-Christophe Luthi; L Duncan Saunders; Cynthia A Beck; Thomas E Feasby; William A Ghali Journal: Med Care Date: 2005-11 Impact factor: 2.983
Authors: Hannah L F Cooper; Joanne E Brady; Daniel Ciccarone; Barbara Tempalski; Karla Gostnell; Samuel R Friedman Journal: Clin Infect Dis Date: 2007-09-25 Impact factor: 9.079
Authors: Lucy E Wilson; David L Thomas; Jacqueline Astemborski; Terri L Freedman; David Vlahov Journal: J Infect Dis Date: 2002-05-31 Impact factor: 5.226
Authors: Alysse G Wurcel; Jordan E Anderson; Kenneth K H Chui; Sally Skinner; Tamsin A Knox; David R Snydman; Thomas J Stopka Journal: Open Forum Infect Dis Date: 2016-07-26 Impact factor: 3.835